3
Participants
Start Date
December 26, 2023
Primary Completion Date
February 23, 2024
Study Completion Date
February 23, 2024
Obeldesivir
Tablet administered orally with or without food
Child Health Care Associates, East Syracuse
Velocity Clinical Research, Charleston, Charleston
Avanza Medical Research Center, Pensacola
UF Health- Shands Hospital, Gainesville
Accel Research Sites Network - Nona Pediatric Center, Orlando
Encore Medical Research LLC, Hollywood
Santos Research Center, Tampa
Pas Research, Tampa
Trinity Clinical Research, LLC, Centreville
Velocity Clinical Research, Omaha, Omaha
Velocity Clinical Research, Norfolk, Norfolk
Texas Children's Hospital, Houston
The University of Texas Medical School at Houston, Houston
PanAmerican Clinical Research, LLC, Brownsville
Velocity Clinical Research -Albuquerque, Albuquerque
Pas Research, Las Vegas
Advanced Research Center, Inc., Anaheim
Stanford University Medical Center, Palo Alto
Lead Sponsor
Gilead Sciences
INDUSTRY